
Akzo Nobel N.V (AKZA) | Financial Analysis & Statements
Akzo Nobel N.V. | Large-cap | Basic Materials
Akzo Nobel N.V. | Large-cap | Basic Materials
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
10.7B
Gross Profit
4.3B
40.49%
Operating Income
917.0M
8.56%
Net Income
592.0M
5.53%
EPS (Diluted)
€3.16
Balance Sheet Metrics
Total Assets
14.2B
Total Liabilities
9.4B
Shareholders Equity
4.8B
Debt to Equity
1.96
Cash Flow Metrics
Operating Cash Flow
388.0M
Free Cash Flow
367.0M
Revenue & Profitability Trend
Akzo Nobel N.V Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 10.7B | 10.7B | 10.8B | 9.6B | 8.5B |
Cost of Goods Sold | 6.4B | 6.4B | 6.9B | 5.7B | 4.7B |
Gross Profit | 4.3B | 4.2B | 3.9B | 3.9B | 3.8B |
Operating Expenses | 1.9B | 3.5B | 1.8B | 1.6B | 1.5B |
Operating Income | 917.0M | 1.0B | 708.0M | 1.1B | 963.0M |
Pre-tax Income | 838.0M | 784.0M | 602.0M | 1.1B | 919.0M |
Income Tax | 246.0M | 296.0M | 214.0M | 246.0M | 241.0M |
Net Income | 592.0M | 483.0M | 378.0M | 865.0M | 671.0M |
EPS (Diluted) | €3.16 | €2.59 | €2.01 | €4.46 | €3.28 |
Income Statement Trend
Akzo Nobel N.V Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 5.8B | 6.0B | 6.2B | 5.3B | 5.1B |
Non-Current Assets | 8.4B | 8.5B | 8.5B | 8.5B | 8.1B |
Total Assets | 14.2B | 14.6B | 14.7B | 13.9B | 13.2B |
Liabilities | |||||
Current Liabilities | 4.7B | 5.7B | 5.7B | 4.9B | 3.1B |
Non-Current Liabilities | 4.7B | 4.3B | 4.4B | 3.4B | 4.1B |
Total Liabilities | 9.4B | 10.0B | 10.2B | 8.2B | 7.2B |
Equity | |||||
Total Shareholders Equity | 4.8B | 4.5B | 4.5B | 5.6B | 6.0B |
Balance Sheet Composition
Akzo Nobel N.V Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 592.0M | 488.0M | 388.0M | 859.0M | 678.0M |
Operating Cash Flow | 388.0M | 968.0M | 177.0M | 184.0M | 576.0M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Investing Cash Flow | 175.0M | 142.0M | -831.0M | 139.0M | -194.0M |
Financing Activities | |||||
Dividends Paid | -385.0M | -368.0M | -379.0M | -391.0M | -385.0M |
Financing Cash Flow | -684.0M | -827.0M | 1.1B | -974.0M | -353.0M |
Free Cash Flow | 367.0M | 840.0M | -29.0M | 317.0M | 962.0M |
Cash Flow Trend
Akzo Nobel N.V Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
21.27
Forward P/E
12.77
Price to Book
2.14
Price to Sales
0.93
PEG Ratio
12.77
Profitability Ratios
Profit Margin
4.38%
Operating Margin
7.65%
Return on Equity
10.71%
Return on Assets
3.76%
Financial Health
Current Ratio
1.36
Debt to Equity
121.08
Beta
0.99
Per Share Data
EPS (TTM)
€2.72
Book Value per Share
€27.06
Revenue per Share
€62.56
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
akza | 9.9B | 21.27 | 2.14 | 10.71% | 4.38% | 121.08 |
DSM-Firmenich AG | 24.6B | 99.74 | 1.10 | 1.22% | 1.95% | 23.26 |
IMCD N.V | 6.6B | 22.93 | 2.97 | 14.12% | 5.86% | 81.58 |
OCI N.V | 1.6B | 27.05 | 0.71 | -7.87% | 510.59% | 35.77 |
Holland Colours N.V | 97.2M | 16.50 | 1.51 | 9.36% | 5.24% | 1.26 |
Prosus N.V | 107.2B | 10.61 | 3.53 | 18.09% | 132.98% | 34.53 |
Financial data is updated regularly. All figures are in the company's reporting currency.